Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study
OBJECTIVES Bilirubin is an endogenous antioxidant that protects cells against oxidative stress. Increased plasma levels of bilirubin have been associated with a reduced risk of ischemic heart disease (IHD) in previous studies. Nonetheless, whether those associations reflect a true protective effect...
Main Authors: | Christina Jeon, Ji-Young Lee, Sun Ju Lee, Keum Ji Jung, Heejin Kimm, Sun Ha Jee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Epidemiology
2019-07-01
|
Series: | Epidemiology and Health |
Subjects: | |
Online Access: | http://e-epih.org/upload/pdf/epih-41-e2019034.pdf |
Similar Items
-
Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference
by: McArdle Patrick F, et al.
Published: (2012-03-01) -
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses
by: Nazlisadat Seyed Khoei, et al.
Published: (2020-09-01) -
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study
by: Nazlisadat Seyed Khoei, et al.
Published: (2021-02-01) -
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
by: Lei Luo, et al.
Published: (2018-12-01) -
Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
by: Jinqiu Zhao, et al.
Published: (2021-08-01)